levamisole has been researched along with fluorouracil in 305 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (13.44) | 18.7374 |
| 1990's | 167 (54.75) | 18.2507 |
| 2000's | 82 (26.89) | 29.6817 |
| 2010's | 14 (4.59) | 24.3611 |
| 2020's | 1 (0.33) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Rees, RB | 1 |
| Haskell, CM | 1 |
| Bedikian, A; Bodey, GP; Burgess, MA; Hersh, EM; Mavligit, GM; Rodriguez, V; Valdivieso, M | 1 |
| Bedikian, AY; Bodey, GP; Burgess, MA; Mavligit, GM; Rodriguez, V; Valdivieso, M | 1 |
| Mason, B; Stephens, EJ; Wood, HF | 1 |
| Benjamin, RS; Blumenschein, GR; Bodey, GP; Buzdar, AU; Gutterman, JU; Hortobagyi, GN; Krutchik, AN; Tashima, CK; Yap, HY | 1 |
| Blumenschein, GR; Burgess, MA; Buzdar, AU; Gutterman, JU; Hersh, EM; Hortobagyi, GN; Tashima, CK; Yap, HY | 1 |
| Christophersen, IS; Lundbeck, F | 1 |
| Blumenschein, GR; Buzdar, AU; Gutterman, JU; Hersh, EM; Hortobagyi, GN; Tashima, CK; Yap, HY | 1 |
| Alburn, HE; Fenichel, RL; Gregory, FJ | 1 |
| Kovach, JS; Schaid, DJ; Svingen, PA | 1 |
| Rivoire, M | 1 |
| Moertel, CG | 1 |
| Neu, IS; Ober, H | 1 |
| Scott, L; Silverberg, DA; Tweedy, CR | 1 |
| O'Connell, MJ | 2 |
| Glimelius, B; Påhlman, L | 2 |
| Wagener, DJ; Wils, J | 1 |
| Nelson, H | 1 |
| Steinke, B | 1 |
| Mitomi, T; Noto, T | 1 |
| Callens, M; De Brabander, M; De Coster, R; Distelmans, W; Jagers, E; Janssen, PA; Janssens, B; Van Ginckel, R; Wouters, L | 1 |
| Forsyth, PA; Hook, CC; Kimmel, DW; Kvols, LK; Moertel, CG; Rodriguez, M; Rubin, J; Scheithauer, BW | 1 |
| Lee, MW | 1 |
| Frenzel, H; Kröger, N | 1 |
| Groshen, S; Muggia, FM | 1 |
| Ducreux, M | 1 |
| Grem, JL | 2 |
| Harvey, VJ | 1 |
| Havemann, K; Pflüger, KH; Rothmund, M | 1 |
| DeVita, VT | 1 |
| Mulder, NH | 1 |
| Clarke, M; Gray, R; Labianca, R; Liberati, A; Marsoni, S; Pancera, G; Taiana, A; Torri, V | 1 |
| Hossfeld, DK | 1 |
| Eisenhauer, E; Erlichman, C; Germond, C; Kerr, I; Levine, M; Lofters, W; Maroun, J; Rayner, HL; Skillings, JR; Yoshida, S | 1 |
| Green, M; Wirth, A; Zalcberg, JR | 1 |
| Hutson, PR; Mutch, RS | 1 |
| Bulger, KN; Hesketh, PJ | 1 |
| Schlag, P | 1 |
| Gray, R; Slevin, M | 1 |
| Cheson, BD | 2 |
| Friedman, MA; Hamilton, JM; Sznol, M | 1 |
| Burtin, P; Cosset, JM | 1 |
| Currie, V; Geller, NL; Hakes, TB; Kaufman, R; Petroni, GR | 1 |
| Theve, T | 1 |
| Joseph, RR; Treat, J | 1 |
| Porschen, R; Stremmel, W | 1 |
| Cleton, FJ; Welvaart, K; Zwaveling, A | 1 |
| Seitz, JF | 1 |
| Emerson, WA; Fleming, TR; Glick, JH; Goodman, PJ; Haller, DG; Laurie, JA; Macdonald, JS; Moertel, CG; Tormey, DC; Ungerleider, JS | 1 |
| Mayer, RJ | 1 |
| Ling, HY; Wang, NZ; Zhu, HZ | 1 |
| Marx, JL | 1 |
| Fleming, TR; Gerstner, JB; Krook, JE; Laurie, JA; Leigh, JE; Malliard, J; McCormack, GW; Moertel, CG; Rubin, J; Wieand, HS | 1 |
| Allegra, CJ; Grem, JL | 1 |
| Smigel, K | 1 |
| Buroker, TR; Cullinan, SA; Everson, LK; Fleming, TR; Klaassen, DJ; Krook, JE; Laurie, JA; Mailliard, JA; Marschke, RF; Moertel, CG | 1 |
| Brincker, H; Christensen, JJ; Frederiksen, PL; Johansen, H; Laursen, F; Nybo-Rasmussen, A; Overgaard, M; Panduro, J; Sørensen, NE; van der Kooy, P | 1 |
| Bell, PR; Shaw, D; Windle, R | 1 |
| Carpenter, JT; Raney, M; Smalley, RV; Vogel, CL; Weiner, RS | 1 |
| Guarneri, D; Nobile, MT; Porcile, G; Rosso, R; Rubagotti, A; Sertoli, MR | 1 |
| Kas'ianenko, IV; Moroz, TD; Timoshenko, IaG; Zinevich, AK | 1 |
| Ikeya, T; Ishikawa, H; Izuo, M; Kaneko, H; Miyamoto, Y; Seki, M; Takeshita, M; Tozuka, S; Usui, R | 1 |
| House, AK; Maley, MA | 2 |
| Goto, Y; Ishikawa, M; Kaito, I; Kikkawa, J; Kikuchi, K; Matsuoka, T; Ono, K; Sugahara, K; Taima, T; Takahashi, K; Wakui, A; Yokoyama, M; Yoshida, Y | 1 |
| Koziol, M; Mikolajski, K; Rozek-Lesiak, K; Scheller, S | 1 |
| Furue, H; Furusawa, M; Hattori, T; Inokuchi, K; Ito, I; Niimoto, M; Ogawa, N; Orita, K; Tamada, R; Toda, T | 1 |
| Dimopoulos, C; Giannopoulos, A; Kioupkiolis, G; Lykourinas, M | 1 |
| Sabala, PI | 1 |
| Akai, S; Fujii, G; Hattori, T; Hayasaka, H; Inoue, G; Izuo, M; Kubo, K; Nomura, Y; Ogawa, N; Okamoto, T; Ota, K; Sakai, K; Taguchi, T; Tazima, S; Tominaga, T; Yoshida, M | 1 |
| Hamada, S | 1 |
| Kobayashi, T; Miwa, H; Ono, F; Orita, K | 1 |
| Abe, O; Fujimoto, S; Furue, H; Furusawa, M; Hashimoto, I; Hattori, T; Inokuchi, K; Itoh, I; Koga, S; Kondo, T; Niimoto, M; Ogawa, N; Ohya, M; Orita, K; Sugiyama, Y; Tamada, R; Toda, T | 1 |
| Furue, H; Furusawa, M; Hattori, T; Hioki, K; Hirano, M; Inokuchi, K; Itoh, I; Iwanaga, T; Izuo, M; Kondo, T; Kosaki, G; Miura, K; Niimoto, M; Ogawa, N; Orita, K; Taguchi, T; Takemiya, S; Tamada, R; Tomita, M; Tsuji, H; Yura, J | 1 |
| Matsuoka, T; Saito, T; Sato, K; Sato, Y; Takahashi, K; Wakui, A | 1 |
| Brunskill, DE; Herbick, JM; Mansell, PW; McKinney, EC; Miller, AM; Padgett, DC; Silverman, MA; Sugarbaker, EV; Thompson, JS; Vogel, CL | 1 |
| Bancewicz, J; Calman, KC; Macpherson, SG; McArdle, CS; McVie, JG; Soukop, M | 1 |
| Beelen, RH; Heuff, G; Meyer, S; Peters, GJ; Schuurman, B; Sirovich, I; van der Wilt, CL | 1 |
| Norum, J | 1 |
| Herrmann, R; Rochlitz, CF | 1 |
| Betzing, KW; Holcombe, RF; Kannan, K; Stewart, RM | 1 |
| Fuchs, CS; Mayer, RJ | 1 |
| Dobranowski, J; Fawcet, SE; Figueredo, AT; Molloy, DW; Paulseth, JE | 1 |
| de Man, BM; de Waard, JW; Hendriks, T; van der Linden, CJ; Wobbes, T | 2 |
| Sinicrope, FA; Sugarman, SM | 1 |
| Badellino, F; Cafiero, F; Di Somma, C; Gipponi, M; Percivale, P; Peressini, A; Scarpati, D; Sertoli, MR | 1 |
| Stenram, U | 1 |
| Healy, JB | 1 |
| Takimoto, CH | 1 |
| Reynolds, T | 1 |
| AbdAlla, EE; Blair, GE; Johnston, D; Jones, RA; Sue-Ling, HM | 1 |
| Chan, KK; Muggia, FM | 1 |
| Davey, NC; Enterline, DS; Tien, RD | 1 |
| Leicester, RJ; Mansi, JL; Rayter, Z | 1 |
| Hamilton, JM | 1 |
| Ajao, OG; al Shehri, MY; Grillo, IA; Malatani, T | 1 |
| Lin, DY | 1 |
| Emerson, WA; Fleming, TR; Glick, JH; Haller, DG; Laurie, JA; Macdonald, JS; Mailliard, JA; Moertel, CG; Tangen, CM; Tormey, DC; Ungerleider, JS; Veeder, MH | 1 |
| Abbott, R; Critchley, P; Madden, FJ | 1 |
| Bleiberg, H | 2 |
| Apuzzo, ML; Atkinson, RD; Chen, TC; Couldwell, WT; Hinton, DR; Leichman, L | 1 |
| Ilson, DH; Kelsen, DP | 1 |
| Bertino, JR; Cohen, AM; Enker, W; Kelsen, DP; Saltz, L; Tao, Y; Tong, W; Yao, TJ | 1 |
| Mezger, J | 1 |
| Bernstein, M; Davidson, G; Erlichman, C; Villamil, A | 1 |
| Bjarnason, GA; Hamilton, P; Kwan, W | 1 |
| Fassas, AB; Gattani, AM; Morgello, S | 1 |
| Israel, MK; Scarfe, MA | 1 |
| Fleming, TR; Glidden, D; Pepe, MS; Prentice, RL | 1 |
| Bleiberg, H; Rougier, P; Wils, J | 1 |
| Fabri, MC; Grandjouan, S | 1 |
| Forman, WB | 1 |
| Schlag, PM | 1 |
| Fowler, WC; Gerçel-Taylor, C; Taylor, DD; Weese, JL | 1 |
| Kimball, ES | 1 |
| Brown, ML; Nayfield, SG; Shibley, LM | 1 |
| Fleming, TR; Haller, DG; Laurie, JA; Macdonald, JS; Moertel, CG; Tangen, C | 1 |
| Fine, S | 1 |
| Beerblock, K; de Gramont, A; Demuynck, B; Grangé, JD; Krulik, M; Louvet, C; Navarro-Carola, E; Soubrane, D; Varette, C | 1 |
| Cassidy, J | 1 |
| Schmoll, HJ | 1 |
| Köhne-Wömpner, CH; Schmoll, HJ; Schöffski, P | 1 |
| Fleming, TR; Haller, DG; Laurie, JA; Macdonald, JS; Moertel, CG | 1 |
| Grado, GL; Maples, WJ; Marschke, RF; Martenson, JA; Schutt, AJ | 1 |
| Farthmann, E; Harder, F; Herfarth, C; Laffer, U; Schlag, PM; Wilke, H | 1 |
| de Souza, P | 1 |
| Nordlinger, B; Rougier, P | 1 |
| Kurman, MR | 1 |
| Neu, IS | 1 |
| Kimmel, DW; Schutt, AJ | 1 |
| Gurney, H; Hall, J; Harnett, PR; Smith, RD | 1 |
| Emerson, WA; Fleming, TR; Glick, JH; Haller, DG; Laurie, JA; Macdonald, JS; Moertel, CG; Tangen, CM; Tormey, DC; Ungerleider, JS | 1 |
| Slevin, ML | 1 |
| Cersosimo, RJ; Lee, JM | 1 |
| Atkins, CD | 1 |
| Gordon, J; Licho, R; Litofsky, NS; Ragland, R; Recht, L; Savarese, DM; Smith, TW | 1 |
| Raskov, HH | 1 |
| Babu, KG; Kumaraswamy, SV; Lalitha, N; Raud, C | 1 |
| Estes, NC; Fabian, C; Giri, S | 1 |
| Brown, TD | 1 |
| Toge, T | 1 |
| Bécouarn, Y; Brunet, R; Giovannini, M; Perrier, H; Rouhier, ML; Seitz, JF | 1 |
| Bechade, D; Blanc, JF; Buecher, B; Lapprand, M; Magnien, F; Oddes, B | 1 |
| Blijham, GH | 1 |
| Wils, J | 2 |
| Barbieri, F; Crisi, G; Luppi, G; Piccinini, L; Silingardi, V; Zoboli, A | 1 |
| Angeles, A; DeJong, L; Garcia, Y; Grant, A; Leichman, CG; Leichman, L; Poplin, E; Zalupski, M | 1 |
| Bertolani, L; Galassi, G; Mavilla, L; Sintini, M; Spagnoli, M; Tassone, G | 1 |
| Erlichman, C; Goldberg, RM; Kahn, MJ; O'Connell, MJ; Shepherd, LE | 1 |
| Parmar, MK; Simon, R; Ungerleider, RS | 1 |
| Bonistalli, L; Costantini, M; Messori, A; Tendi, E; Trallori, G | 1 |
| Cohen, SA; Doerr, RJ; Johnkoski, JA; Peterson, SM | 1 |
| Alberti, D; Arzoomanian, R; Carbone, P; Cleary, JF; Feierabend, C; Storer, B; Wilding, G; Witt, P | 1 |
| Siderov, J; Simes, J; Zalcberg, JR | 1 |
| Norum, J; Olsen, JA; Revhaug, A; Vonen, B | 1 |
| Benson, AB; Cooke, E; Cummings, B; Gunderson, LL; Hollis, D; Macdonald, JS; Martenson, JA; O'Connell, MJ; Petroni, GR; Tepper, JE | 1 |
| Heinicke, JM; Hess, P; Laffer, UT | 1 |
| Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Hsu, H; Lin, JK; Lin, TC; Liu, JH; Wang, WS; Yen, CC | 1 |
| Haller, DG; Vaughn, DJ | 1 |
| Kimmel, DW; Lucchinetti, CF; Pavelko, K; Rodriguez, M | 1 |
| Ford, WJ; Heros, D; Murray, CL; Sperduto, PW; Swenson, KK | 1 |
| Cohen, A; Kemeny, N; Saltz, L | 1 |
| Tveit, KM | 1 |
| Ahn, MJ; Choi, JS; Kim, JC; Kim, SH; Kim, SK; Kim, SW; Kim, WG; Lee, JH; Lee, JS; Lee, KH; Lee, MS; Park, KC; Suh, CW; Zang, DY | 1 |
| Donohue, JH; Erlichman, C; Figueredo, A; Fitzgibbons, RJ; Kahn, M; Kocha, WI; Krook, JE; Laurie, JA; Moertel, CG; O'Connell, MJ; Pazdur, R; Rubin, J; Shepherd, L; Vukov, AM; Wieand, HS | 1 |
| Drews, M; Fundowicz, D; Paszkowski, J; Szmeja, J; Wierzbicki, T; Załuski, J | 1 |
| Fietkau, R | 1 |
| Ahnen, DJ; Bunn, PA; Feigl, P; Fenoglio-Preiser, C; Lovato, LC; Macdonald, JS; Meyskens, FL; Quan, G; Stemmerman, G; Wells, JD | 1 |
| Galassi, G; Marchi, M; Santini, A; Sintini, M | 1 |
| Filho, WD; Lopes, A; Nakagawa, WT; Novaes, PE; Rossi, BM | 1 |
| Bagniewski, PG; Kovach, JS; Moertel, CG; O'Connell, MJ; Reid, JM | 1 |
| Bandealy, MT; Einhorn, LH; Gonin, R; Loehrer, PJ; Monaco, F | 1 |
| Burger, D; Depisch, D; Greiner, R; Karner, J; Kornek, GV; Kovats, E; Marczell, A; Ritschel, J; Salem, G; Scheithauer, W; Schneeweiss, B; Stöger, F; Vischer, HM | 1 |
| Hahn, EG; Herfarth, C; Hohenberger, W; Kohnen, R; Lehnert, T; Reingruber, B; Riedel, C; Teichmann, W; Wakker, R; Wein, A | 1 |
| Bours, V; Fillet, G; Jerusalem, G | 1 |
| Brown, MC | 1 |
| Louvet, C | 1 |
| Figueredo, A; Fine, S; Maroun, J; Walker-Dilks, C; Wong, S | 1 |
| Browman, G; Figueredo, A; Germond, C; Maroun, J; Walker-Dilks, C; Wong, S | 1 |
| Levin, B; Pazdur, R; Sinicrope, FA | 1 |
| Papamichael, D; Rougier, P; Schmoll, HJ; Slevin, ML | 1 |
| Chabot, J; Ishak, KG; Lefkowitch, J; Marvin, MR | 1 |
| Ang, PT; Au, E; Chng, HC; Low, CH; Ng, BK; Seow-Choen, F; Soo, KC | 1 |
| Moiseenko, VM; Orlova, RV | 1 |
| Ben Abdesselem, M; Ben Ayed, F; Ben Safta, Z; Benna, F; Boussen, H; Dhouib, R; Dziri, C; el May, M; Gammoudi, A; Hamza, H; Jerbi, G; Kallel, N; Khomsi, F; Najah, N; Rahal, K; Zaouche, A | 1 |
| Adebamowo, CA; Ajao, OG; Ladipo, JK; Okeke, LI; Soyannwo, OA | 1 |
| Chan, YL; Tong, MM; Yeo, W | 1 |
| Bernhard, J; Herrmann, R; Hürny, C; Laffer, U; Maibach, R | 1 |
| Burch, PA; Dalton, RJ; Ebbert, LP; Gerstner, JB; Jancewicz, MT; Keppen, MD; Krook, JE; Rubin, J; Schroeder, G | 1 |
| Atkins, JN; Bear, HD; Dimitrov, NV; Fisher, B; Fisher, ER; Glass, AG; Jones, J; Mamounas, E; Rockette, H; Wickerham, DL; Wieand, S; Wolmark, N | 1 |
| Elsaleh, H; Grieu, F; Iacopetta, B; Joseph, D; Soontrapornchai, P | 1 |
| Betzing, KS; Dakhil, SR; Holcombe, RF; Jacobson, J; Kannan, K; Macdonald, JS; Stewart, RM | 1 |
| Büchele, T; Dempke, W; Grothey, A; Schmoll, HJ | 1 |
| Elsaleh, H; Goria, F; Iacopetta, B; Joseph, D; Powell, B; Soontrapornchai, P; Spry, N | 1 |
| Connolly, M; Ding, C; Gwilt, P; Kremer, A; Tempero, M | 1 |
| Barak, V; Israel, ZH; Lossos, A; Siegal, T; Soffer, D | 1 |
| Schallhorn, A | 1 |
| Schumacher, K | 1 |
| Bleeker, WA; Hermans, J; Mulder, NH; Otter, R; Plukker, JT | 2 |
| Cohen, Y; Ezekiel, G; Walfisch, S | 1 |
| Barnwell, J; Gray, R; Kerr, DJ; McConkey, C | 1 |
| Bertoglio, S; Cafiero, F; Gipponi, M; Lionetto, R; Peressini, A | 1 |
| Cunningham, D; Waters, JS | 1 |
| Mamounas, EP | 1 |
| Kodaira, S; Nozawa, K; Shatari, T | 1 |
| Bock, PR; Hanisch, J; Kulig, J; Kłek, S; Popiela, T; Wachol, D | 1 |
| Anger, Y; Bermann, A; Haack, G; Löffler, T; Porschen, R; Rettig, K; Strohmeyer, G | 1 |
| Barylak, E; Cnaan, A; Harris, JE; Mansour, EG; Schutt, AJ; Witte, RS | 1 |
| Piedbois, P | 1 |
| Kerr, DJ | 1 |
| Colangelo, L; Wieand, S; Wolmark, N | 1 |
| Cheng, PW; Cheung, RT; Mak, W | 1 |
| Glimelius, B; Hafström, L; Nygren, P; Ragnhammar, P | 1 |
| Bernhard, J; Hürny, C; Lowy, A; Maibach, R | 1 |
| Francini, G; Goldberg, RM; Haller, DG; Jacobson, SD; Labianca, R; Macdonald, JS; Sargent, DJ; Seitz, JF; Shepherd, LE | 1 |
| Maughan, TS | 1 |
| Taal, BG; Van Tinteren, H; Zoetmulder, FA | 1 |
| Blomgren, H; Edler, D; Glimelius, B; Hallström, M; Jakobsen, A; Johnston, PG; Magnusson, I; Ragnhammar, P | 1 |
| Benson, AB; Cummings, B; Gunderson, LL; Hollis, DR; Macdonald, JS; Martenson, JA; Mayer, RJ; Niedzwiecki, D; O'Connell, M; Tepper, JE | 1 |
| Bernath, A; Craig, G; Ellison, N; Fata, F; Gallagher, J; Law, A; Mirza, A; Nair, S | 1 |
| Boige, V; Ducreux, M | 1 |
| Iacopetta, B | 1 |
| Dencausse, Y; Fritze, D; Hagmüller, E; Hartung, G; Kopp-Schneider, A; Lindemann, H; Queisser, W; Sturm, J; Wojatschek, C | 1 |
| Erlichman, C; Hobday, TJ | 1 |
| Punt, CJ | 1 |
| Arkenau, HT; Bermann, A; Porschen, R; Rettig, K; Strohmeyer, G | 1 |
| Haydon, A | 1 |
| Grinev, MV | 1 |
| Comte, S; Lebrun, T; Selke, B | 1 |
| Henne-Bruns, D; Link, KH; Staib, L | 1 |
| Cunningham, D; Rao, S | 1 |
| Cafiero, F; Gipponi, M; Lionetto, R | 1 |
| König, HH; Leidl, R; Link, KH; Monz, BU; Staib, L | 1 |
| Eckert, GJ; Grieshop, NA; Loehrer, PJ; Sidner, RA; Wiebke, EA | 1 |
| Benson, AB; Catalano, PJ; Fuchs, CS; Haller, DG; Macdonald, JS; Mayer, RJ; Meyerhardt, JA | 1 |
| Hwang, YH; Park, SP; Suh, CK | 1 |
| Gray, R; Hills, R; Stowe, R | 1 |
| Boni, C; Bruzzi, P; Comandone, A; Conte, P; Di Costanzo, F; Dogliotti, L; Falcone, A; Folco, U; Frassineti, L; Galli, C; Gallo, L; Gasperoni, S; Lionetto, R; Luppi, G; Marzola, M; Mestriner, M; Pfanner, E; Rosso, R; Sobrero, A; Tonato, M; Turci, D | 1 |
| Imanishi, T; Kamigaki, T; Kuroda, Y | 1 |
| Hirata, K; Nishikawa, N; Sasaki, K; Takasaka, H; Yoshikawa, T | 1 |
| Murakami, M; Naito, M; Ota, T; Shimizu, N; Tsukuda, K | 1 |
| Bascioni, R; Cascinu, S; Catalano, G; Catalano, V; Cellerino, R; Giorgi, F; Marcellini, M; Mattioli, R; Pancotti, A; Pieroni, V; Piga, A; Silva, RR; Torresi, U | 1 |
| Alberts, SR; Benedetti, J; Cha, SS; Chen, W; Francini, G; Francois Seitz, J; Gill, S; Goldberg, RM; Haller, DG; Heldebrant, MP; Labianca, R; Loprinzi, CL; Sargent, DJ; Shepherd, LE; Thomé, SD | 1 |
| Gal, R; Klein, B; Koren, R; Sadikov, E; Sulkes, J | 1 |
| Andre, T; de Gramont, A | 1 |
| Benson, AB; Donohue, JH; Fisher, B; Goldberg, RM; Gunderson, LL; Mailliard, JA; Martenson, JA; Myerson, R; Sargent, DJ; Thomas, CR; Willett, CG | 1 |
| Balafouta, M; Dimitrakopoulos, A; Felekouras, E; Fotiadis, K; Gennatas, K; Gouveris, P; Karatzas, G; Kosmas, C; Kouraklis, G; Papalambros, E; Papastratis, G; Paraskevaidis, M; Safioleas, M; Skopelitis, HM; Tsavaris, N; Vasiliou, J; Voros, D; Zacharakis, M; Zografos, G | 1 |
| Scheithauer, W | 1 |
| Haller, DG; Sun, W | 1 |
| Benedetti, JK; Estes, NC; Goldberg, RM; Haller, DG; Macdonald, JS; Mayer, RJ; Poplin, EA; Rivkin, SE; Weiss, GR | 1 |
| Gnant, M; Hausmaninger, H; Hofbauer, F; Holzberger, P; Jagoditsch, M; Jakesz, R; Mischinger, HJ; Mittlböck, M; Mlineritsch, B; Schaberl-Moser, R; Schippinger, W; Sorré, C; Steger, G | 1 |
| Agnese, V; Bazan, V; Calò, V; Cicero, G; Colucci, G; Corsale, S; Dardanoni, G; Gebbia, N; Grassi, N; Latteri, MA; Russo, A; Tomasino, RM; Valerio, MR; Vieni, S | 1 |
| Arnaud, JP; Baila, L; Bedenne, L; Bleiberg, H; Bouché, O; Conroy, T; Debois, M; Grobost, O; Guimares dos Santos, J; Lacourt, J; Lasser, P; Mackiewickz, R; Morin, T; Nordlinger, B; Ollier, JC; Rougier, P; Seitz, JF; van Cutsem, E; Wals, J; Wils, J | 1 |
| Beger, HG; Kornmann, M; Kron, M; Link, KH; Redenbacher, M; Staib, L | 1 |
| Adamo, V; Bianco, AR; Carlomagno, C; Cortesi, E; De Placido, S; De Vita, F; Farris, A; Ficorella, C; Gallo, C; Gebbia, N; Gemini, M; Iannace, C; Ianniello, GP; Lopez, M; Manzione, L; Palazzo, S; Palmeri, S; Paoletti, G; Perrone, F; Persico, G; Pistillucci, G | 1 |
| Catalano, PJ; Frontiera, MS; Haller, DG; Jackson, DV; Macdonald, JS; Mayer, RJ; O'Rourke, MA | 1 |
| Albertsson, M; Bentzen, SM; Cedermark, B; Dahl, O; Glimelius, B; Grönberg, H; Hultborn, R; Jakobsen, A; Påhlman, L; Starkhammar, H; Tveit, KM | 1 |
| Greene, FL; Jessup, JM; Minsky, BD; Stewart, A | 1 |
| Costa, F; Van Cutsem, E | 1 |
| Dong, QM; He, YJ; Li, YH | 1 |
| Davis, MD; Link, JS; Weick, JA | 1 |
| Cheng, Y; Shen, Y | 1 |
| Atkins, JN; Benedetti, JK; Benson, AB; Cripps, C; Estes, NC; Fisher, B; Haller, DG; Kugler, JW; Leichman, CG; Macdonald, JS; Maher, T; Martenson, JA; Mayer, RJ; Pedersen, J; Periman, PO; Rich, TA; Robertson, JM; Smalley, SR; Tanaka, MS; Williamson, SK | 1 |
| Krook, JE; Kugler, JW; Mahoney, MR; Morton, RF; O'Connell, MJ; Rayson, S; Rowland, KM; Sargent, DJ; Shepherd, L; Windschitl, HE | 1 |
| Eriksen, MT; Haffner, J; Wibe, A; Wiig, JN | 1 |
| Barnwell, J; Gray, R; Hills, RK; Kerr, DJ; McConkey, C; Williams, NS | 1 |
| Ghebremichael, M | 1 |
| Choi, GS; Jun, SH; Kang, BM; Lim, KH; Park, IJ | 1 |
| Bjerkeset, O; Carlsen, E; Dahl, O; Eide, TJ; Fluge, Ø; Halvorsen, TB; Myrvold, HE; Podhorny, N; Tveit, KM; Vonen, B; Wiig, JN | 1 |
| Andersen, J; Andersson, M; Ejlertsen, B; Jensen, MB; Kamby, C; Knoop, AS; Mouridsen, HT | 1 |
| Cinieri, S; Colucci, G; Fazio, N; Lombardi, L; Maiello, E; Morelli, F; Orlando, L; Santini, D; Silvestris, N; Tonini, G | 1 |
| Benedetti, JK; Blackstock, AW; Dignam, JJ; Goldberg, RM; O'Connell, MJ; Saltz, LB; Sargent, DJ; Wolmark, N; Yothers, G | 1 |
| Dahl, O; Elsaleh, H; Fluge, Ø; Knudsen, ES; Leh, S; Li, Z; Myklebust, MP; Myrvold, HE; Pestell, RG; Rui, H; Tran, TH; Tveit, KM; Vonen, B | 1 |
| Chiou, HY; Hsieh, LL; Lai, CY; Sung, FC; Tang, R; Wu, FY; Yeh, CC | 1 |
| Hwang, YH; Kang, DH; Kim, JH; Kim, YS; Kim, YW; Park, SP; Song, HS | 1 |
| Brydøy, M; Dahl, O; Hestetun, KE; Myklebust, MP | 1 |
| Boye, K; Dahl, O; Flatmark, K; Frikstad, KA; Jacob, H; Maelandsmo, GM; Nesbakken, A; Nesland, JM | 1 |
| Dahl, O; Leh, S; Myklebust, MP; Stanisavljević, L | 1 |
| Nordlund, JJ | 1 |
| Mu, R; Xu, J | 1 |
| Coley, H; Kadakia, KC; Salem, ME; Worrilow, WM | 1 |
70 review(s) available for levamisole and fluorouracil
| Article | Year |
|---|---|
Current dermatologic therapy.
Topics: Acne Vulgaris; Administration, Topical; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Betamethasone; Cryosurgery; Dermatomycoses; Flucytosine; Fluocinonide; Fluorouracil; Herpes Simplex; Humans; Keratosis; Levamisole; Propylene Glycols; Psoriasis; Pyoderma; Skin Diseases; Skin Neoplasms; Vitamin A; Warts | 1976 |
Immunologic aspects of cancer chemotherapy.
Topics: Animals; BCG Vaccine; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Levamisole; Mercaptopurine; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; Vinca Alkaloids | 1977 |
Accomplishments in surgical adjuvant therapy for large bowel cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Drug Therapy, Combination; Fluorouracil; Humans; Levamisole; Randomized Controlled Trials as Topic; Rectal Neoplasms; Semustine | 1992 |
Chemotherapy of colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Humans; Levamisole; Prognosis; Rectal Neoplasms | 1992 |
The value of adjuvant therapy after radical surgery for colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Lomustine; Neoplasm Recurrence, Local; Postoperative Care; Radiography; Radiotherapy Dosage; Sweden | 1992 |
Advances in adjuvant chemotherapy for colon cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Portal Vein; Prospective Studies; Randomized Controlled Trials as Topic | 1992 |
[Combined therapy with 5-FU and levamisole].
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Levamisole; Neoplasm Transplantation; Stomach Neoplasms | 1992 |
Colorectal cancer. Recent developments and continuing controversies.
Topics: Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Mass Screening; Monitoring, Physiologic; Rectal Neoplasms; Risk Factors | 1992 |
Adjuvant therapy of colon cancer: lessons while looking for breakthroughs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Levamisole; Portal Vein | 1991 |
Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Lymph Nodes | 1991 |
[Adjuvant therapy in colonic carcinoma].
Topics: Carcinoma; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care | 1991 |
Adjuvant therapy of colorectal cancer: an overview.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole | 1991 |
Levamisole in the adjuvant treatment of colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Intestinal Absorption; Levamisole; Methotrexate | 1991 |
Role of adjuvant therapy in colorectal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole; Radiotherapy | 1991 |
5-Fluorouracil plus levamisole: effective adjuvant treatment for colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemistry, Clinical; Colonic Neoplasms; Colorectal Neoplasms; Combined Modality Therapy; Drug Evaluation; Fluorouracil; Humans; Immunity, Cellular; Levamisole; Neoplasm Recurrence, Local; Stimulation, Chemical | 1990 |
Consensus panel considers adjuvant therapy for colon and rectal cancer, identifies levamisole--fluorouracil as standard in colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; United States | 1990 |
[Adjuvant chemotherapy in colonic cancer].
Topics: Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Levamisole; Postoperative Care; Recurrence; Semustine | 1990 |
Adjuvant chemotherapy for colon and rectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Immunotherapy; Infusions, Intravenous; Leucovorin; Levamisole; Liver Neoplasms; Neoplasm Staging; Portal Vein; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Rectal Neoplasms; Treatment Failure | 1995 |
Role of adjuvant therapy in surgically resected colorectal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Immunotherapy; Leucovorin; Levamisole; Lymphatic Metastasis; Prognosis; Radiotherapy, Adjuvant; Rectal Neoplasms | 1995 |
Adjuvant chemotherapy for colorectal cancer.
Topics: Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Neoplasm Staging; Prognosis | 1995 |
Adjuvant therapy for gastrointestinal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Digestive System Neoplasms; Fluorouracil; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Incidence; Leucovorin; Levamisole; Radiotherapy, Adjuvant; Survival Rate; Treatment Outcome | 1994 |
[Adjuvant chemotherapy in cancers of the colon and rectum].
Topics: Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Rectal Neoplasms | 1994 |
Adjuvant postoperative therapy of gastrointestinal malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Doxorubicin; Fluorouracil; Gastrointestinal Neoplasms; Humans; Levamisole; Mitomycin; Pancreatic Neoplasms; Rectal Neoplasms; Semustine; Stomach Neoplasms | 1994 |
[Adjuvant therapy in colorectal carcinomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Folic Acid; Humans; Levamisole; Prospective Studies; Radiotherapy, Adjuvant; Rectal Neoplasms; Semustine; Vincristine | 1994 |
Cerebral demyelination with 5-fluorouracil and levamisole.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Colorectal Neoplasms; Demyelinating Diseases; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged | 1994 |
[Adjuvant chemotherapy in colonic cancers].
Topics: Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Heparin; Humans; Leucovorin; Levamisole; Liver Neoplasms; Semustine | 1994 |
The role of chemotherapy and adjuvant therapy in the management of colorectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Rectal Neoplasms | 1994 |
[Adjuvant systemic chemo- or immunotherapy of colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Humans; Immunotherapy; Leucovorin; Levamisole; Neoplasm Staging; Survival Rate | 1994 |
Experimental modulation of IL-1 production and cell surface molecule expression by levamisole.
Topics: Animals; Bone Marrow; Cell Adhesion Molecules; Fluorouracil; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Levamisole; Macrophages; Tumor Cells, Cultured | 1993 |
An overview of adjuvant treatment of colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Levamisole; Portal Vein | 1993 |
Colorectal carcinoma: current problems and future perspectives.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Forecasting; Humans; Immunotherapy; Levamisole; Mass Screening; Neoplasm Staging; Portal Vein; Risk Factors | 1994 |
Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Immunotherapy; Leucovorin; Levamisole; Mitomycin; Randomized Controlled Trials as Topic | 1994 |
Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Infusions, Parenteral; Leucovorin; Levamisole; Male; Portal Vein; Rectal Neoplasms; Risk Factors | 1993 |
Recent clinical trials with levamisole.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Nephrotic Syndrome | 1993 |
[Adjuvant systemic chemotherapy in colon cancer].
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Prognosis | 1996 |
[Progress of adjuvant chemotherapy in colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Survival Rate | 1996 |
[Immunotherapy of colorectal cancers].
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; BCG Vaccine; Colorectal Neoplasms; Cytokines; Drug Therapy, Combination; Fluorouracil; Humans; Immunotherapy, Active; Levamisole | 1996 |
Adjuvant therapy of colon cancer: towards a new consensus.
Topics: Antinematodal Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole | 1996 |
Multifocal leukoencephalopathy associated with 5-fluorouracil and levamisole adjuvant therapy for colon cancer. A report of two cases and review of the literature. The INTACC. Intergruppo Nazionale Terpia Adiuvante Colon Carcinoma.
Topics: Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leukoencephalopathy, Progressive Multifocal; Levamisole; Middle Aged | 1996 |
The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Dose-Response Relationship, Drug; Fluorouracil; Humans; Levamisole; Randomized Controlled Trials as Topic | 1996 |
The role of adjuvant chemotherapy in the treatment of colorectal cancer.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Immunotherapy; Levamisole; Neoplasm Staging; Rectal Neoplasms | 1997 |
Adjuvant therapy of colorectal cancer.
Topics: Adjuvants, Immunologic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Forecasting; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Portal Vein; Prognosis; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Rate | 1997 |
[Adjuvant treatment for colon carcinoma. Results and perspectives].
Topics: Adjuvants, Immunologic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Germany; Humans; Immunotherapy; Leucovorin; Levamisole; Practice Guidelines as Topic; Prognosis; Societies, Medical | 1998 |
[What's new in adjuvant therapy of colorectal cancers?].
Topics: Adjuvants, Immunologic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Staging; Prognosis; Treatment Outcome | 1998 |
[Adjuvant therapy for colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Staging; Randomized Controlled Trials as Topic; Russia; Survival Analysis; Treatment Outcome; United States | 1998 |
Where do we stand with 5-fluorouracil?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Chronotherapy; Colorectal Neoplasms; Dipyridamole; Drug Synergism; Fluorouracil; Humans; Interferons; Leucovorin; Levamisole; Methotrexate; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Trimetrexate; Zidovudine | 1999 |
[Adjuvant chemotherapy for colorectal carcinoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Levamisole; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic | 2000 |
Adjuvant therapy in high-risk colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Immunotherapy; Leucovorin; Levamisole | 2000 |
[Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Levamisole; Mitomycin; Randomized Controlled Trials as Topic; Semustine; Survival Rate; Tegafur; Uracil; Vincristine | 2000 |
A systematic overview of chemotherapy effects in colorectal cancer.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Dose-Response Relationship, Drug; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Neoplasm Staging; Palliative Care; Portal Vein; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Survival Analysis | 2001 |
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.
Topics: Adenocarcinoma; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Multivariate Analysis; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Survival Analysis | 2001 |
Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.
Topics: Adenocarcinoma; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Levamisole; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Registries; Survival Rate | 2002 |
Adjuvant chemotherapy for colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Immunotherapy; Leucovorin; Levamisole; Neoplasm Staging; Treatment Outcome | 2002 |
Adjuvant therapy of colon cancer: a review.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Immunotherapy; Irinotecan; Leucovorin; Levamisole; Neoplasm Staging | 2002 |
Adjuvant chemotherapy in colon cancer: what is the evidence?
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Evidence-Based Medicine; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Staging; Randomized Controlled Trials as Topic | 2003 |
[Economic assessment of adjuvant and palliative chemotherapy in colorectal cancer: a review].
Topics: Antineoplastic Agents; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; France; Humans; Irinotecan; Leucovorin; Levamisole; Palliative Care; Quality-Adjusted Life Years; Quinazolines; Thiophenes | 2003 |
Adjuvant therapy for colon cancer in the new millenium.
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Therapy, Combination; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Levamisole; Neoplasm Staging; Randomized Controlled Trials as Topic | 2003 |
[Adjuvant chemotherapy for colorectal cancer: Its efficacy and problems].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Evidence-Based Medicine; Fluorouracil; Humans; Leucovorin; Levamisole; Meta-Analysis as Topic; Treatment Outcome | 2003 |
[Home chemotherapy and outpatient treatment for metastatic colorectal cancer].
Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Fatal Outcome; Female; Fluorouracil; Home Care Services; Humans; Infusions, Intravenous; Irinotecan; Levamisole; Liver Neoplasms; Middle Aged; Quality of Life | 2003 |
[Adjuvant chemotherapy for colorectal carcinoma after curative resection].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colectomy; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Evidence-Based Medicine; Fluorouracil; Humans; Leucovorin; Levamisole; Pharmacogenetics; Polymorphism, Genetic; Prognosis | 2003 |
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; United States | 2004 |
An overview of adjuvant systemic chemotherapy for colon cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Levamisole; Organoplatinum Compounds; Oxaliplatin; Prognosis; Randomized Controlled Trials as Topic | 2004 |
[Advances in palliative and adjuvant chemotherapy of colon cancer].
Topics: Antineoplastic Agents; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Leucovorin; Levamisole; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Tegafur; Uracil | 2004 |
Adjuvant therapy of colon cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Irinotecan; Leucovorin; Levamisole; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis | 2005 |
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Treatment Outcome | 2005 |
[Progression of adjuvant chemotherapy for colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Irinotecan; Leucovorin; Levamisole; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin | 2005 |
Adjuvant treatment of colon cancer: past, present and future.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Deoxycytidine; Disease-Free Survival; ErbB Receptors; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Levamisole; Organoplatinum Compounds; Oxaliplatin; Survival Rate | 2007 |
Adjuvant colon cancer chemotherapy: where we are and where we'll go.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Loss of Heterozygosity; Lymphatic Metastasis; Microsatellite Instability; Neoplasm Staging; Predictive Value of Tests; Prognosis; Survival Rate | 2010 |
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Confounding Factors, Epidemiologic; Disease-Free Survival; Female; Fluorouracil; Health Status Disparities; Healthcare Disparities; Humans; Kaplan-Meier Estimate; Leucovorin; Levamisole; Lomustine; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Proportional Hazards Models; Randomized Controlled Trials as Topic; Treatment Outcome; United States; Vincristine; White People | 2011 |
The Medical Treatment of Vitiligo: An Historical Review.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anthelmintics; Antimalarials; Antimetabolites, Antineoplastic; Calcineurin Inhibitors; Catalase; Clofazimine; Fluorouracil; Folic Acid; History, 16th Century; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Khellin; Leprostatic Agents; Levamisole; Phenylalanine; PUVA Therapy; Vitiligo | 2017 |
99 trial(s) available for levamisole and fluorouracil
| Article | Year |
|---|---|
Sequential chemoimmunotherapy of colorectal cancer: evaluation of methotrexate, Baker's Antifol and levamisole.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Colonic Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms; Remission, Spontaneous; Semustine; Time Factors; Triazines | 1978 |
Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Melphalan; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis | 1978 |
Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
Topics: Adult; Aged; Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Time Factors | 1978 |
The value of adjuvant therapy after radical surgery for colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Lomustine; Neoplasm Recurrence, Local; Postoperative Care; Radiography; Radiotherapy Dosage; Sweden | 1992 |
Is a mechanism such as the NCI's Clinical Alert ever an appropriate alternative to journal peer review?
Topics: Breast Neoplasms; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Information Services; Levamisole; National Institutes of Health (U.S.); Peer Review; Periodicals as Topic; United States | 1991 |
Levamisole in the adjuvant treatment of colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Intestinal Absorption; Levamisole; Methotrexate | 1991 |
Role of adjuvant therapy in colorectal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole; Radiotherapy | 1991 |
Adjuvant therapy for cancer of the colon.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Injections, Intravenous; Levamisole; Portal Vein | 1991 |
[Adjuvant treatment of colonic cancer. An important progress?].
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Survival Analysis | 1990 |
Association of disease-free survival and percent of ideal dose in adjuvant breast chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Levamisole; Menopause; Methotrexate; Retrospective Studies; Survival Analysis | 1990 |
[Adjuvant chemotherapy improves chances of survival in curative surgery of colon cancer, Dukes' stage C].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Complications; Retrospective Studies; Survival Rate | 1990 |
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Patient Compliance; Postoperative Care; Random Allocation | 1990 |
Levamisole with fluorouracil for colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Fluorouracil; Humans; Levamisole; Lymphatic Metastasis; Random Allocation | 1989 |
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Patient Compliance; Random Allocation | 1989 |
Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Female; Fluorouracil; Humans; Immunotherapy; Levamisole; Male; Middle Aged; Postoperative Period; Prognosis; Prospective Studies; Random Allocation; Semustine; Stomach Neoplasms | 1988 |
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Colonic Neoplasms; Drug Evaluation; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Metastasis; Phosphonoacetic Acid; Random Allocation; Rectal Neoplasms; Semustine; Streptozocin; Thymidine; Vincristine | 1985 |
Postmastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Levamisole; Mastectomy, Simple; Methotrexate; Random Allocation; Risk Factors; Tamoxifen | 1988 |
Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancer.
Topics: Adult; Aged; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leukocyte Migration-Inhibitory Factors; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Rectal Neoplasms | 1987 |
Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Levamisole; Neoplasm Metastasis; Random Allocation; Risk | 1986 |
Adjuvant immunochemotherapy in colorectal cancer Dukes C.
Topics: Adjuvants, Immunologic; Clinical Trials as Topic; Colonic Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Male; Random Allocation; Rectal Neoplasms; Remission Induction; Semustine | 1987 |
[Phase III multi-center study of levamisole (LMS)--a randomized evaluation in advanced gastrointestinal cancer, with special reference to stomach cancer].
Topics: Adult; Aged; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Stomach Neoplasms | 1983 |
Levamisole in postoperative adjuvant immunochemotherapy for gastric cancer. A randomized controlled study of the MMC + Tegafur regimen with or without levamisole. Report I.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Levamisole; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Tegafur | 1984 |
[Effect of levamisole hydrochloride on advanced and recurrent breast cancer--LMS randomized controlled study of a group responding to CAF (cyclophosphamide, adriamycin, and 5-FU) therapy].
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Middle Aged; Random Allocation | 1982 |
[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Humans; Leukocyte Count; Levamisole; Lymphocytes; Middle Aged; Mitomycin; Mitomycins; Postoperative Care; Random Allocation; Stomach Neoplasms; Tegafur | 1982 |
[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1].
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antineoplastic; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Stomach Neoplasms | 1982 |
[Clinical evaluation of chemoimmunotherapy for advanced gastrointestinal cancer using a combined regimen of 5-fluorouracil, adriamycin and levamisole].
Topics: Doxorubicin; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplasms; Humans; Levamisole | 1983 |
Adjuvant chemotherapy and immunotherapy for colorectal cancer: preliminary communication.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Immunotherapy; Levamisole; Neutropenia; Prognosis; Random Allocation; Rectal Neoplasms | 1980 |
Adjuvant post-operative radiotherapy vs radiotherapy plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer. A phase III randomized clinical trial. P.A.R. Cooperative Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Rectal Neoplasms; Treatment Outcome | 1995 |
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Levamisole; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Survival Rate | 1995 |
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Female; Floxuridine; Fluorouracil; Humans; Infusions, Parenteral; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Survival Analysis | 1994 |
[Adjuvant therapy in colorectal carcinomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Folic Acid; Humans; Levamisole; Prospective Studies; Radiotherapy, Adjuvant; Rectal Neoplasms; Semustine; Vincristine | 1994 |
Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Data Interpretation, Statistical; Fluorouracil; Humans; Levamisole; Likelihood Functions; Models, Statistical; Neoplasm Staging; Neoplasms; Randomized Controlled Trials as Topic; Research; Survival Analysis; Treatment Outcome | 1994 |
Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Liver Diseases; Liver Function Tests | 1993 |
Prospective phase I evaluation of radiation therapy, 5-fluorouracil, and levamisole in locally advanced gastrointestinal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Gastrointestinal Neoplasms; Humans; Levamisole; Prospective Studies; Radiotherapy | 1994 |
Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Infusions, Parenteral; Leucovorin; Levamisole; Male; Portal Vein; Rectal Neoplasms; Risk Factors | 1993 |
Recent clinical trials with levamisole.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Nephrotic Syndrome | 1993 |
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis | 1995 |
[Adjuvant systemic chemotherapy in colon cancer].
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Prognosis | 1996 |
A pilot trial of continuous infusion 5-fluorouracil with levamisole for adjuvant therapy of colon cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Levamisole; Male; Middle Aged; Pilot Projects | 1996 |
A phase I study of 5-fluorouracil, leucovorin and levamisole.
Topics: Adjuvants, Immunologic; Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Colonic Neoplasms; Diarrhea; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Stomatitis | 1997 |
Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Colostomy; Cost-Benefit Analysis; Female; Fluorouracil; Follow-Up Studies; Health Care Costs; Humans; Length of Stay; Levamisole; Male; Middle Aged; Norway; Quality of Life; Survival Analysis; Survival Rate; Travel | 1997 |
Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Agranulocytosis; Antidotes; Antimetabolites, Antineoplastic; Cause of Death; Chemotherapy, Adjuvant; Combined Modality Therapy; Diarrhea; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Levamisole; Male; Middle Aged; Postoperative Period; Prospective Studies; Rectal Neoplasms; Survival Rate; Treatment Outcome | 1997 |
[The importance of adjuvant chemotherapy in the treatment of colonic carcinoma: SAKK Study 40/93 (Swiss Work Group for Clinical Cancer Research)].
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Mitomycin; Prospective Studies; Quality of Life | 1997 |
Factors predictive of response and survival in patients with metastatic colorectal cancer in Taiwan.
Topics: Adjuvants, Immunologic; Adult; Aged; Antidotes; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections; Leucovorin; Levamisole; Liver Neoplasms; Male; Middle Aged; Prognosis; Remission Induction; Survival Analysis | 1997 |
A randomized trial comparing cisplatin plus 5-fluorouracil with or without levamisole in operable gastric cancer.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Stomach Neoplasms | 1997 |
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Staging; Prospective Studies | 1998 |
[Combined treatment of large bowel cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Palliative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate | 1997 |
Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Topics: Cell Division; Chemotherapy, Adjuvant; Colorectal Neoplasms; DNA, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Genes, ras; Genetic Markers; Humans; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Ploidies; Polymorphism, Single-Stranded Conformational; Prognosis; Survival Analysis | 1998 |
Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Confusion; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Injections, Intravenous; Levamisole; Male; Middle Aged; Neoplasms; Treatment Outcome; Vertigo; Vomiting | 1998 |
Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Double-Blind Method; Female; Fluorouracil; Humans; Levamisole; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Prospective Studies; Survival Rate | 1998 |
Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Antimetabolites, Antineoplastic; Colonic Neoplasms; Disease-Free Survival; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate; Treatment Outcome | 1998 |
Phase I trial of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy for colon carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Sulindac | 1996 |
[Adjuvant chemotherapy after curative surgery for non-metastatic colorectal carcinomas (2-year results of 52 cases)].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 1999 |
Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK)
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Levamisole; Linear Models; Male; Middle Aged; Perception; Quality of Life; Retrospective Studies | 1999 |
North Central Cancer Treatment Group Phase II study of 5-fluorouracil and high-dose levamisole for gastric and gastroesophageal cancer using survival as the primary endpoint of efficacy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Esophageal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Stomach Neoplasms; Survival Rate; United States | 1999 |
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local | 1999 |
Association of immune parameters with clinical outcome in stage III colon cancer: results of Southwest Oncology Group Protocol 9009.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Fluorouracil; Humans; Immunophenotyping; Levamisole; Life Tables; Neoplasm Staging; Survival Analysis; Treatment Outcome | 1999 |
Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil.
Topics: Adjuvants, Immunologic; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Metabolic Clearance Rate; Middle Aged; Time Factors | 2000 |
Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis | 2000 |
[Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Staging | 2000 |
The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Treatment Outcome | 2000 |
[Adjuvant therapy of colon cancer stage C MAC. Adverse effects and efficacy in the Department of Oncology, Soroka Medical Center in the years 1991-1994].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Survival Rate | 1999 |
Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules--less pain, same gain. QUASAR Colorectal Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Treatment Outcome | 2000 |
Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer.
Topics: Adjuvants, Immunologic; Adult; Aged; Analysis of Variance; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis; Treatment Outcome | 2000 |
Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Colonic Neoplasms; Costs and Cost Analysis; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Levamisole; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Physical Examination; Survival Analysis; Tomography, X-Ray Computed; Ultrasonography | 2001 |
Double-blind pilot-study on the efficacy of enzyme therapy in advanced colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chymotrypsin; Colorectal Neoplasms; Disease-Free Survival; Double-Blind Method; Drug Combinations; Fluorouracil; Humans; Levamisole; Neoplasm Metastasis; Pancreatic Extracts; Papain; Pilot Projects; Quality of Life; Survival Rate; Thymus Extracts; Trypsin | 2000 |
Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
Topics: Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome | 2001 |
Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
Topics: Abdominal Neoplasms; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Levamisole; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Survival Analysis; Treatment Outcome | 2001 |
A United Kingdom coordinating committee on cancer research study of adjuvant chemotherapy for colorectal cancer: preliminary results.
Topics: Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Double-Blind Method; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prospective Studies | 2001 |
Response shift in the perception of health for utility evaluation. an explorative investigation.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Attitude to Health; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Health Status Indicators; Humans; Levamisole; Male; Middle Aged; Postoperative Period; Quality of Life; Switzerland | 2001 |
Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Patient Compliance; Rectal Neoplasms; Survival Analysis; Survival Rate; Treatment Outcome | 2001 |
Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
Topics: Adjuvants, Immunologic; Aged; Analysis of Variance; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Survival Analysis; Thymidylate Synthase; Treatment Outcome | 2002 |
Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intravenous; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Rectal Neoplasms; Sex Factors; Survival Analysis; Treatment Outcome | 2002 |
Adjuvant chemotherapy in stage III colon cancer with 5-fluorouracil and levamisole versus 5-fluorouracil and leucovorin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Survival Analysis | 2002 |
5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis | 2003 |
[Interferon-alpha in adjuvant treatment of colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Leucovorin; Levamisole; Neoplasm Staging; Recombinant Proteins; Survival Rate | 2002 |
Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis | 2003 |
Cost effectiveness of adding folinic acid to fluorouracil plus levamisole as adjuvant chemotherapy in patients with colon cancer in Germany.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Female; Fluorouracil; Folic Acid; Germany; Humans; Levamisole; Male; Middle Aged; National Health Programs; Quality-Adjusted Life Years | 2003 |
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Weight; Chemotherapy, Adjuvant; Cohort Studies; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Obesity; Risk Factors; Survival Rate; Treatment Outcome; United States | 2003 |
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Levamisole; Male; Middle Aged; Treatment Outcome | 2003 |
The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Injections, Intravenous; Levamisole; Male; Middle Aged; Treatment Outcome | 2003 |
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Infusions, Intravenous; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Risk Factors; Treatment Outcome | 2004 |
Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Survival Rate; Treatment Outcome | 2004 |
Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Male; Middle Aged | 2005 |
A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Interferon-alpha; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Analysis | 2005 |
Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Survival Analysis | 2005 |
Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Interferon-alpha; Leucovorin; Levamisole; Male; Middle Aged; Patient Compliance; Survival Rate | 2005 |
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Treatment Outcome | 2005 |
Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Dose-Response Relationship, Drug; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Compliance; Risk Factors; Survival Analysis; Treatment Outcome; Vitamin B Complex | 2005 |
Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Staging; Survival Rate | 2005 |
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Staging; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis; Treatment Outcome | 2006 |
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neopterin | 2006 |
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Vitamin B Complex | 2007 |
Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents; Antirheumatic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Norway; Rectal Neoplasms; Survival Rate; Young Adult | 2009 |
Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Levamisole; Methotrexate; Middle Aged; Premenopause | 2010 |
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Combined Modality Therapy; Cyclin D1; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Levamisole; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Recurrence; Treatment Outcome | 2012 |
Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer.
Topics: Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Cell Nucleus; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Rectal Neoplasms; Retrospective Studies; Serpins; Tissue Array Analysis | 2015 |
Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Clinical Decision-Making; Colorectal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Levamisole; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prognosis; S100 Calcium-Binding Protein A4; Treatment Outcome; Tumor Cells, Cultured | 2016 |
LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Topics: AC133 Antigen; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Immunoenzyme Techniques; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled; Survival Rate; Tissue Array Analysis | 2016 |
144 other study(ies) available for levamisole and fluorouracil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Chemoimmunotherapy of metastatic large bowel cancer: nonspecific stimulation with BCG and levamisole.
Topics: BCG Vaccine; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Levamisole; Lomustine; Methotrexate; Neoplasm Metastasis; Rectal Neoplasms; Tegafur | 1977 |
Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancer.
Topics: BCG Vaccine; Breast Neoplasms; Castration; Cyclophosphamide; Doxorubicin; Drug Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Immunotherapy; Levamisole; Menopause; Neoplasm Metastasis; Tegafur | 1979 |
Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Neoplasm Metastasis; Remission, Spontaneous | 1979 |
Phase II study of adriamycin, 5-fluorouracil, levamisole, and irradiation in carcinoma of the bladder.
Topics: Bone Marrow; Carcinoma, Transitional Cell; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Levamisole; Nausea; Remission, Spontaneous; Urinary Bladder Neoplasms | 1979 |
Chemotherapy and breast cancer.
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Methotrexate | 1976 |
Anti-tumour and anti-metastatic activity of 3-(P-Chlorophenyl)-2,3-Dihydro-3-Hydroxythiazolo (3,2-A)-Benzimidazole-2-acetic acid (WY-13,876).
Topics: Animals; Anthelmintics; Antilymphocyte Serum; Antineoplastic Agents; Benzimidazoles; Cyclophosphamide; Fluorouracil; Lethal Dose 50; Levamisole; Lung Neoplasms; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; T-Lymphocytes; Thiazoles; Transplantation, Isogeneic | 1976 |
Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Ethers, Cyclic; Fluorouracil; Humans; Levamisole; Melanoma; Okadaic Acid; Phosphoric Monoester Hydrolases; Skin Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vanadates | 1992 |
[Cancers of the colon and the rectum: news in 1992].
Topics: Amifostine; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole; Rectal Neoplasms | 1992 |
[Multifocal leukoencephalopathy following adjuvant therapy with fluorouracil and levamisole].
Topics: Adenocarcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Fluorouracil; Humans; Leukoencephalopathy, Progressive Multifocal; Levamisole; Male; Middle Aged; Sigmoid Neoplasms | 1992 |
Levamisole-induced syndrome of inappropriate antidiuretic hormone.
Topics: Drug Therapy, Combination; Fluorouracil; Humans; Inappropriate ADH Syndrome; Levamisole; Male; Middle Aged; Sigmoid Neoplasms | 1992 |
Combined modality adjuvant treatment of high-risk rectal cancer: a treatment of choice or a choice of treatment?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Rectal Neoplasms; Semustine | 1992 |
[Adjuvant therapeutic possibilities in carcinoma of colon and rectum].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Colectomy; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole | 1992 |
Levamisole plus 5-fluorouracil inhibits the growth of human colorectal xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Mice; Mice, Nude; Neoplasm Transplantation; Rectal Neoplasms; Transplantation, Heterologous | 1992 |
Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Biopsy; Brain; Chemotherapy, Adjuvant; Colonic Neoplasms; Consciousness Disorders; Demyelinating Diseases; Dexamethasone; Female; Fluorouracil; Humans; Inflammation; Levamisole; Male; Middle Aged | 1992 |
[Adjuvant therapy in colonic carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Staging | 1992 |
[Adjuvant treatment of resected colon cancers using a 5-fluorouracil-levamisole combination].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local; Rectal Neoplasms; Semustine | 1991 |
Adjuvant therapy of colon cancer: what should we be doing.
Topics: Adjuvants, Pharmaceutic; Clinical Trials as Topic; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Neoplasm Staging; New Zealand; Research Design; Survival Analysis | 1991 |
Colon cancer, some progress at last.
Topics: Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole | 1991 |
Efficacy of intraportal infusion for colon cancer: a fair assessment?
Topics: Colonic Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Levamisole; Portal Vein | 1991 |
[Is there a reliable adjuvant (intraoperative) chemotherapy of colorectal cancer?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Neoplasm Staging | 1990 |
Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.
Topics: Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Postoperative Period; Randomized Controlled Trials as Topic | 1991 |
[Treatment of colorectal cancer with antineoplastic agents. Too early to introduce routine adjuvant therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Prognosis | 1991 |
[Adjuvant chemotherapy in colonic carcinoma?].
Topics: Adjuvants, Immunologic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Postoperative Care | 1991 |
[Treatment of colorectal cancers. Recommendations of the French Foundation of Digestive Cancerology].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Digestive System Neoplasms; Fluorouracil; France; Humans; Levamisole; Postoperative Care; Preoperative Care; Rectal Neoplasms; Societies, Medical | 1991 |
Clinical trials referral resource. Adjuvant therapy for colon cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Levamisole; Middle Aged | 1990 |
Levamisole receives FDA imprimatur for colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; United States; United States Food and Drug Administration | 1990 |
[Is levamisole combined with fluorouracil efficient in colorectal cancer?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local | 1990 |
New findings in treatment of colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Prognosis | 1990 |
Levamisole approved for use in adjuvant regimen for colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Levamisole | 1990 |
[Adjuvant treatment of colon and rectum carcinoma: one step ahead].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Rectal Neoplasms | 1990 |
Does adjuvant therapy work in colon cancer?
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole | 1990 |
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.
Topics: Colonic Neoplasms; Combined Modality Therapy; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Humans; Levamisole | 1990 |
5-Fluorouracil and levamisole in colorectal carcinoma.
Topics: Adjuvants, Immunologic; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole | 1990 |
[Preliminary study of traditional Chinese medicine-Western medicine treatment of patients with primary liver carcinoma].
Topics: Adjuvants, Immunologic; Adult; Camptothecin; Carcinoma, Hepatocellular; Cimetidine; Drugs, Chinese Herbal; Female; Fluorouracil; Humans; Levamisole; Liver Neoplasms; Male; Middle Aged | 1989 |
Clinical trials referral resource. Adjuvant treatment of colon cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Clinical Trials as Topic; Colonic Neoplasms; Combined Modality Therapy; Drug Synergism; Fluorouracil; Humans; Interferon-gamma; Leucovorin; Levamisole; Somatostatin | 1989 |
Drug availability is an issue for cancer patients, too.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local | 1989 |
Toxicity of levamisole and 5-fluorouracil in human colon carcinoma cells.
Topics: Clone Cells; Colonic Neoplasms; Drug Administration Schedule; Drug Synergism; Fluorouracil; Humans; Levamisole; Tumor Cells, Cultured | 1989 |
Adjuvant therapy benefits Dukes' C colon cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Levamisole | 1989 |
[Factor analysis of immunologic reactivity indices in patients with inoperable stomach cancer].
Topics: Adult; Aged; Antineoplastic Agents; Factor Analysis, Statistical; Female; Fluorouracil; Humans; Immunologic Tests; Levamisole; Male; Middle Aged; Stomach Neoplasms | 1986 |
[5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Levamisole; Stomach Neoplasms; Tegafur; Time Factors; Uracil | 1985 |
Immune capability of rats with colorectal carcinoma treated by resection with or without 5-fluorouracil or levamisole.
Topics: Animals; B-Lymphocytes; Cell Migration Inhibition; Colonic Neoplasms; Cytotoxicity, Immunologic; Fluorouracil; Leukocyte Count; Leukocytes; Levamisole; Lymphocytes; Male; Rats; Rats, Inbred Strains; Rectal Neoplasms | 1984 |
[Evaluation of the efficiency of the immune system after immunostimulation in patients with breast cancer].
Topics: Adult; BCG Vaccine; Breast Neoplasms; Complement System Proteins; Cyclophosphamide; Female; Fluorouracil; Humans; Immunization; Immunoglobulins; Levamisole; Lysine; Middle Aged; Muramidase; Properdin; Vincristine | 1983 |
The place of chemotherapy associated with active immunotherapy with levamisol in advanced bladder cancer.
Topics: Combined Modality Therapy; Doxorubicin; Fluorouracil; Humans; Immunotherapy; Levamisole; Urinary Bladder Neoplasms | 1984 |
[Individualization of polychemotherapy for stage III breast cancer based on immunologic status].
Topics: Adult; Aged; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Immunity, Cellular; Levamisole; Lymphocyte Activation; Methotrexate; Middle Aged; Prednisolone; Prognosis; Vincristine | 1984 |
Clinical and in vivo response following surgery or surgery plus adjuvant chemotherapy or immunotherapy for colorectal carcinoma in a rat model.
Topics: Animals; Colonic Neoplasms; Combined Modality Therapy; Disease Models, Animal; Fluorouracil; Levamisole; Male; Rats; Rats, Inbred Strains; Rectal Neoplasms | 1983 |
[Anticancer effect of levamisole and tegafur on 1,2-dimethylhydrazine (DMH)-induced colonic cancers in rats].
Topics: 1,2-Dimethylhydrazine; Animals; Antineoplastic Agents; Colonic Neoplasms; Dimethylhydrazines; Fluorouracil; Levamisole; Male; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Tegafur | 1982 |
[Effect of immunochemotherapy on the cases of advanced gastric cancer stage III].
Topics: Drug Therapy, Combination; Fluorouracil; Gastrectomy; Humans; Levamisole; Lymphatic Metastasis; Mitomycin; Mitomycins; Neoplasm Staging; Stomach Neoplasms | 1982 |
Mechanisms of levamisole-induced granulocytopenia in breast cancer patients.
Topics: Acute Disease; Adult; Aged; Agranulocytosis; B-Lymphocytes; Breast Neoplasms; Colony-Forming Units Assay; Concanavalin A; Cyclophosphamide; Cytotoxicity, Immunologic; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Hemagglutination Tests; Humans; Levamisole; Methotrexate; Middle Aged; Phytohemagglutinins; T-Lymphocytes | 1980 |
The combination 5-fluorouracil/levamisole induces enhanced rat Kupffer cell-mediated cytotoxicity in vitro against the syngeneic colon adenocarcinoma cell line CC531.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Analysis of Variance; Animals; Cell Separation; Cells, Cultured; Colonic Neoplasms; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Fluorouracil; Kupffer Cells; Levamisole; Male; Rats; Rats, Inbred Strains; Tumor Cells, Cultured | 1995 |
5-Fluorouracil/levamisole induced intrahepatic fat infiltration imitating liver metastasis.
Topics: Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Diagnosis, Differential; Fatty Liver; Fluorouracil; Humans; Levamisole; Liver; Liver Neoplasms; Male; Radiography; Rectal Neoplasms | 1995 |
[Adjuvant treatment of colonic carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Fluorouracil; Humans; Immunotherapy; Leucovorin; Levamisole; Lomustine | 1995 |
Alteration in lymphocyte phenotype associated with administration of adjuvant levamisole and 5-fluorouracil.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; CD56 Antigen; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Killer Cells, Natural; Levamisole; Lymphocytes; Phenotype; Receptors, Interleukin-2 | 1994 |
Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant therapy for resected colorectal cancer: a report of two cases.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Diseases; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Dementia; Female; Fluorouracil; Humans; Levamisole; Male | 1995 |
Post-operative levamisole may compromise early healing of experimental intestinal anastomoses.
Topics: Anastomosis, Surgical; Animals; Collagen; Fluorouracil; Hydroxyproline; Intestines; Leucovorin; Levamisole; Male; Postoperative Care; Pressure; Rats; Rats, Wistar; Wound Healing | 1995 |
Re: Mechanism of synergy of levamisole and fluorouracil: induction of human leukocyte antigen class I in a colorectal cancer cell line.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Synergism; Fluorouracil; Histocompatibility Antigens Class I; Levamisole; Pilot Projects; Rats; RNA, Neoplasm; Tumor Cells, Cultured | 1995 |
Re: Enigma of fluorouracil and levamisole.
Topics: Antimetabolites, Antineoplastic; Fluorouracil; Folic Acid; Humans; Leucovorin; Levamisole; Neoplasms | 1995 |
Enigma of fluorouracil and levamisole.
Topics: Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Levamisole; RNA, Neoplasm | 1995 |
Dutch trial casts doubt on colorectal adjuvant therapy.
Topics: Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Drug Therapy, Combination; Europe; Fluorouracil; Humans; Levamisole; Treatment Outcome | 1995 |
Mechanism of synergy of levamisole and fluorouracil: induction of human leukocyte antigen class I in a colorectal cancer cell line.
Topics: beta 2-Microglobulin; Blotting, Northern; Colorectal Neoplasms; DNA Probes; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Fluorouracil; Genes, MHC Class I; Humans; Levamisole; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1995 |
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Floxuridine; Fluorouracil; Humans; Leucovorin; Levamisole | 1995 |
Neuroradiology case of the day. Multifocal inflammatory leukoencephalopathy due to treatment with 5-fluorouracil and levamisole.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Colonic Neoplasms; Demyelinating Diseases; Fluorouracil; Humans; Levamisole; Male; Middle Aged | 1995 |
Colo-rectal carcinoma in a tropical African population: an overview report.
Topics: Adenocarcinoma; Administration, Rectal; Adolescent; Adult; Aged; Anus Neoplasms; Ascites; Colonic Neoplasms; Combined Modality Therapy; Defecation; Female; Fluorouracil; Humans; Injections, Intraperitoneal; Injections, Intravenous; Levamisole; Male; Middle Aged; Nigeria; Rectal Neoplasms; Survival Rate; Treatment Outcome; Tropical Climate | 1994 |
Cox regression analysis of multivariate failure time data: the marginal approach.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bias; Clinical Trials as Topic; Cluster Analysis; Colonic Neoplasms; Diabetic Retinopathy; Female; Fluorouracil; Humans; Infections; Levamisole; Longitudinal Studies; Male; Markov Chains; Monte Carlo Method; Multivariate Analysis; Prognosis; Proportional Hazards Models; Recurrence; Schizophrenia; Software | 1994 |
Multifocal inflammatory leukoencephalopathy developing in a patient receiving 5-fluorouracil and levamisole.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain; Chemotherapy, Adjuvant; Colonic Neoplasms; Demyelinating Diseases; Female; Fluorouracil; Humans; Levamisole; Magnetic Resonance Imaging | 1994 |
Multifocal inflammatory leukoencephalopathy associated with levamisole and 5-fluorouracil: case report.
Topics: Aged; Cerebral Cortex; Chemotherapy, Adjuvant; Colonic Neoplasms; Cytokines; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Leukoencephalopathy, Progressive Multifocal; Levamisole; Macrophage Activation; Neoplasm Staging; Neurologic Examination | 1994 |
Necrosis in a meningioma following systemic chemotherapy. Case report.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Embolization, Therapeutic; Fluorouracil; Humans; Leucovorin; Levamisole; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Necrosis; Neoplasms, Multiple Primary; Radiotherapy Dosage; Rectal Neoplasms | 1994 |
Adjuvant therapy with fluorouracil and levamisole and liver ultrasound mimicking liver metastases.
Topics: Adult; Colonic Neoplasms; Diagnosis, Differential; Fatty Liver; Female; Fluorouracil; Humans; Levamisole; Liver; Liver Neoplasms; Ultrasonography | 1994 |
Possible drug interaction between warfarin and combination of levamisole and fluorouracil.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Interactions; Fluorouracil; Humans; Levamisole; Male; Warfarin | 1994 |
Adjuvant treatment of colon cancer. A plea for a large-scale European trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Randomized Controlled Trials as Topic | 1994 |
Enhancement of antitumor effects of combined chemoimmunotherapy.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; CD4-Positive T-Lymphocytes; Chemotherapy, Adjuvant; Disease Models, Animal; Fluorouracil; Immunotherapy; Levamisole; Lung Neoplasms; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Thymopentin | 1993 |
Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Computer Simulation; Cost-Benefit Analysis; Fluorouracil; Humans; Levamisole; Neoplasm Staging; Quality of Life | 1994 |
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Fluorouracil; Humans; Levamisole; Neoplasm Recurrence, Local; Sensitivity and Specificity | 1993 |
[Toxicity of levamisole in adjuvant chemotherapy for colorectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole; Retrospective Studies | 1993 |
Adjuvant 5-fluorouracil plus levamisole in colon cancer: the plot thickens?
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; National Institutes of Health (U.S.); United Kingdom; United States | 1994 |
[Is adjuvant chemotherapy of colon cancers (Dukes C; TxN+) regarded as standard today?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Neoplasm Staging; Survival Rate | 1993 |
A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Fluorouracil; Humans; Levamisole; Neoplasm Staging; Quality of Life; Value of Life | 1993 |
Multifocal inflammatory leukencephalopathy caused by adjuvant therapy with 5-fluorouracil and levamisole after resection for an adenocarcinoma of the colon.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Demyelinating Diseases; Fluorouracil; Humans; Levamisole; Male; Middle Aged | 1993 |
Multifocal leukoencephalopathy: occurrence during 5-fluorouracil and levamisole therapy and resolution after discontinuation of chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Leukoencephalopathy, Progressive Multifocal; Levamisole; Male; Middle Aged | 1993 |
A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Cost-Benefit Analysis; Costs and Cost Analysis; Cross-Sectional Studies; Female; Fluorouracil; Follow-Up Studies; Health Status; Humans; Levamisole; Life Expectancy; Male; Middle Aged; Neoplasm Staging; Quality of Life; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 1993 |
Adjuvant treatment for colorectal cancer.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Randomized Controlled Trials as Topic | 1996 |
Creatine kinase elevation associated with 5-fluorouracil and levamisole therapy for carcinoma of the colon. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Creatine Kinase; Fluorouracil; Humans; Isoenzymes; Levamisole; Male | 1996 |
Inflammatory bowel disease associated with levamisole and fluorouracil chemotherapy for colon cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Inflammatory Bowel Diseases; Levamisole; Male; Middle Aged | 1996 |
Cerebral demyelination syndrome in a patient treated with 5-fluorouracil and levamisole. The use of thallium SPECT imaging to assist in noninvasive diagnosis--a case report.
Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Agents; Brain Diseases; Colonic Neoplasms; Demyelinating Diseases; Female; Fluorouracil; Humans; Levamisole; Magnetic Resonance Imaging; Tomography, Emission-Computed | 1996 |
Carcinoma colon with mandible and liver metastases.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Liver Neoplasms; Male; Mandibular Neoplasms; Palliative Care; Radiotherapy, Adjuvant | 1996 |
Patterns of recurrence for advanced colon cancer modified by whole abdominal radiation and chemotherapy.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Retrospective Studies; Treatment Failure | 1996 |
Chemotherapy in stage II/Duke's B2 colon cancer: tolerable but necessary?
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Levamisole; Neoplasm Staging; Postoperative Care | 1996 |
[Severe myalgias: an unusual undesirable effect of levamisole combined with 5-fluorouracil].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Colonic Neoplasms; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorouracil; Humans; Levamisole; Middle Aged; Muscular Diseases | 1996 |
Adjuvant treatment of colorectal cancer in The Netherlands: a commentary.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Fluorouracil; Humans; Levamisole; Netherlands | 1996 |
5-Fluorouracil- and levamisole-associated multifocal leukoencephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Leukoencephalopathy, Progressive Multifocal; Levamisole; Magnetic Resonance Imaging; Middle Aged | 1996 |
Optimal duration of fluorouracil plus levamisole colon cancer surgical adjuvant therapy.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Levamisole | 1996 |
Assessing whether to perform a confirmatory randomized clinical trial.
Topics: Adjuvants, Immunologic; Bayes Theorem; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Lung Neoplasms; Neoplasms; Observer Variation; Randomized Controlled Trials as Topic; Reproducibility of Results; Survival Analysis; Treatment Outcome | 1996 |
Cost effectiveness of adjuvant intraportal chemotherapy in patients with colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cost-Benefit Analysis; Drug Administration Schedule; Economics, Pharmaceutical; Fluorouracil; Heparin; Humans; Levamisole; Mitomycins; Portal System; Survival Rate | 1996 |
Levamisole regulates the proliferation of murine liver T cells through Kupffer-cell-derived cytokines.
Topics: Adjuvants, Immunologic; Animals; Bone Marrow; Bone Marrow Cells; Fluorouracil; Interferon Type I; Kupffer Cells; Levamisole; Liver; Lymphocyte Activation; Mice; Mice, Inbred C57BL; T-Lymphocytes | 1996 |
5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus.
Topics: Adjuvants, Immunologic; Animals; Antimetabolites, Antineoplastic; Demyelinating Diseases; Female; Fluorouracil; Genetic Predisposition to Disease; Levamisole; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Myelin Sheath; Poliomyelitis; Reference Values; Spinal Cord; Theilovirus | 1997 |
Multifocal inflammatory leukoencephalopathy after fluorouracil and levamisole therapy for colon cancer.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Brain; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Leukoencephalopathy, Progressive Multifocal; Levamisole; Magnetic Resonance Imaging; Middle Aged | 1997 |
[Adjuvant treatment in operable colonic and rectal cancer. A new possibility].
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Rectal Neoplasms | 1997 |
[No improvement of therapeutic results by modulation of 5-fluorouracil with leucovorin and/or levamisole in adjuvant radiochemotherapy in rectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Humans; Leucovorin; Levamisole; Prognosis; Rectal Neoplasms | 1997 |
MRI and 5-fluorouracil-levamisole chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Levamisole; Magnetic Resonance Imaging; Middle Aged | 1998 |
Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial.
Topics: Abdomen; Adenocarcinoma; Adjuvants, Immunologic; Anal Canal; Antidotes; Antimetabolites, Antineoplastic; Brachytherapy; Cesium Radioisotopes; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Iridium Radioisotopes; Leucovorin; Levamisole; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peritoneum; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Survival Rate; Treatment Outcome; Treatment Refusal | 1998 |
Inhibition of fibroblast collagen synthesis and proliferation by levamisole and 5-fluorouracil.
Topics: Adjuvants, Immunologic; Anastomosis, Surgical; Animals; Antineoplastic Agents; Cell Division; Collagen; Drug Combinations; Drug Synergism; Fibroblasts; Fluorouracil; Levamisole; Male; Rats; Rats, Wistar; Wound Healing | 1998 |
[How I treat colorectal cancer. I. Prevention and adjuvant treatment].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Belgium; Chemotherapy, Adjuvant; Colonic Neoplasms; Diet; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Rate | 1998 |
Interaction between warfarin and 5-fluorouracil, not between warfarin and levamisole.
Topics: Adjuvants, Immunologic; Anticoagulants; Antimetabolites, Antineoplastic; Drug Interactions; Female; Fluorouracil; Humans; Levamisole; Prothrombin Time; Warfarin | 1998 |
Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
Topics: Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Staging; Randomized Controlled Trials as Topic | 1997 |
Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
Topics: Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Fluorouracil; Humans; Immunotherapy; Levamisole; Randomized Controlled Trials as Topic | 1997 |
Is there a standard adjuvant treatment for colon cancer?
Topics: Antidotes; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Protocols; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Routes; Fluorouracil; Humans; Immunotherapy; Levamisole; Prognosis | 1998 |
Long-term survival of a young woman with peripheral cholangiocarcinoma: a case report.
Topics: Adult; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemotherapy, Adjuvant; Cholangiocarcinoma; Disease-Free Survival; Female; Fluorouracil; Hepatectomy; Humans; Levamisole; Time Factors | 1999 |
Adjuvant chemotherapy for patients with resected Dukes' C and high-risk B2 colon cancer with fluorouracil and levamisole.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Singapore; Treatment Outcome | 1998 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24-1999. Neurologic disorder in a 65-year-old man after treatment of colon cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Diseases; Cognition Disorders; Colonic Neoplasms; Demyelinating Diseases; Diagnosis, Differential; Fluorouracil; Gait; Humans; Levamisole; Magnetic Resonance Imaging; Male; Movement Disorders | 1999 |
Experience with 5-fluoro-uracil and levamisole in the management of advanced rectal carcinoma.
Topics: Adjuvants, Immunologic; Adult; Antimetabolites, Antineoplastic; Colostomy; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Levamisole; Male; Medicine, African Traditional; Middle Aged; Nigeria; Quality of Life; Rectal Neoplasms; Survival Analysis; Treatment Outcome | 1996 |
Multifocal cerebral demyelination secondary to fluorouracil and levamisole therapy.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Brain; Demyelinating Diseases; Fluorouracil; Humans; Levamisole; Magnetic Resonance Imaging; Male; Middle Aged | 1999 |
P53 alterations have no prognostic or predictive significance in Dukes' C rectal carcinomas.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; DNA, Neoplasm; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Levamisole; Male; Middle Aged; Mutation; Polymorphism, Single-Stranded Conformational; Predictive Value of Tests; Prognosis; Rectal Neoplasms; Survival Analysis; Survival Rate; Tumor Suppressor Protein p53 | 1999 |
p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Colonic Neoplasms; Female; Fluorouracil; Genes, p53; Humans; Levamisole; Male; Microsatellite Repeats; Mutation; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome | 2000 |
Multifocal demyelinative leukoencephalopathy associated with 5-fluorouracil and levamisole.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Dementia, Vascular; Demyelinating Diseases; Diagnosis, Differential; Female; Fluorouracil; Humans; Levamisole; Middle Aged | 2000 |
Adjuvant chemotherapy.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Levamisole; Survival Analysis | 2000 |
Adjuvant chemotherapy for stage II colon cancer: the time has come.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Fluorouracil; Humans; Levamisole; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Recurrence | 2000 |
Fourth International Conference on Colorectal Cancer: adjuvant treatment of colon cancer--introduction.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Therapy, Combination; Fluorouracil; Humans; Interferon-alpha; Levamisole; Meta-Analysis as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Education as Topic | 2001 |
North Central Cancer Treatment Group--Mayo Clinic trials in colon cancer.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Irinotecan; Leucovorin; Levamisole | 2001 |
National Surgical Adjuvant Breast and Bowel Project trials in colon cancer.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Levamisole; Neoplasm Staging; Semustine; Tegafur; Vincristine | 2001 |
Leukoencephalopathy following chemotherapy for colonic carcinoma.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Dementia, Vascular; Dexamethasone; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Treatment Outcome | 2001 |
Adjuvant chemotherapy for colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Levamisole; Microsatellite Repeats; Neoplasm Staging; Prognosis; Treatment Outcome | 2001 |
A biological perspective on the selection of stage II colorectal cancer patients for adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Patient Selection; Prognosis; Risk Assessment; Survival Analysis; Treatment Outcome | 2002 |
Performing phase III clinical trials: never an easy task.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Leucovorin; Levamisole; Neoplasm Staging; Selection Bias | 2002 |
[Cytoreductive surgery as an alternative to palliative operations in oncology (the model of treatment of stage IV colorectal cancer)].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colon; Colorectal Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Immunotherapy; Leucovorin; Levamisole; Male; Neoplasm Metastasis; Palliative Care; Quality of Life; Rectum; Time Factors | 2002 |
Antitumor effects of 5-fluorouracil on human colon cancer cell lines: antagonism by levamisole.
Topics: Antimetabolites, Antineoplastic; Cell Cycle; Cell Division; Colonic Neoplasms; DNA; Dose-Response Relationship, Drug; Drug Interactions; Flow Cytometry; Fluorouracil; Humans; Levamisole; S Phase; Tumor Cells, Cultured | 2003 |
Multifocal inflammatory leukoencephalopathy: use of thallium-201 SPECT and proton MRS.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Aspartic Acid; Axons; Biopsy; Brain; Brain Neoplasms; Choline; Colorectal Neoplasms; Diagnosis, Differential; Fluorouracil; Humans; Lactic Acid; Leukoencephalopathy, Progressive Multifocal; Levamisole; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Metastasis; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2003 |
Anything in modulation?
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Levamisole; Research Design | 2003 |
Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Topics: Adjuvants, Immunologic; Aged; Antimetabolites, Antineoplastic; Carcinoma; Cell Adhesion Molecules; Chemotherapy, Adjuvant; Colectomy; Colorectal Neoplasms; DCC Receptor; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Receptors, Cell Surface; Survival Analysis; Treatment Outcome; Tumor Suppressor Proteins | 2004 |
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease Progression; Female; Fluorouracil; Humans; Leucovorin; Levamisole; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Mutation; Neoplasm Staging; Prospective Studies; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Tumor Suppressor Protein p53 | 2005 |
Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.
Topics: Adjuvants, Immunologic; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Black People; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Utilization; Female; Fluorouracil; Humans; Levamisole; Male; Middle Aged; Neoplasm Staging; Prognosis; Proportional Hazards Models; Sex Factors; Survival Analysis; United States; White People | 2005 |
Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice?
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Neoplasm Staging; United States | 2005 |
Response of predominantly recalcitrant cutaneous warts to topical chemotherapy.
Topics: Administration, Cutaneous; Deoxyglucose; Drug Therapy, Combination; Fluorouracil; Humans; Keratolytic Agents; Levamisole; Medical Records; Minnesota; Recurrence; Retrospective Studies; Salicylic Acid; Skin Diseases; Surveys and Questionnaires; Warts | 2006 |
Adaptive design: estimation and inference with censored data in a semiparametric model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Computer Simulation; Confidence Intervals; Data Interpretation, Statistical; Fluorouracil; Levamisole; Neoplasm Recurrence, Local; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2007 |
Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fluorouracil; Humans; Levamisole; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Norway; Patient Selection; Prognosis; Proportional Hazards Models; Radiotherapy, Adjuvant; Rectal Neoplasms; Registries; Survival Rate; Treatment Outcome | 2007 |
Nonparametric estimation of mean residual functions.
Topics: Algorithms; Analysis of Variance; Antineoplastic Agents; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colorectal Neoplasms; Confidence Intervals; Disease-Free Survival; Fluorouracil; Humans; Levamisole; Placebos; Sample Size; Statistics, Nonparametric; Survival Analysis | 2009 |
Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Elective Surgical Procedures; Female; Fluorouracil; Follow-Up Studies; Humans; Laparoscopy; Laparotomy; Levamisole; Male; Middle Aged; Neoplasm Invasiveness; Postoperative Complications; Prospective Studies; Radiotherapy, Adjuvant; Rectal Neoplasms; Tegafur; Treatment Outcome | 2009 |
Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Colorectal Neoplasms; Drug Combinations; ErbB Receptors; Female; Fluorouracil; Follow-Up Studies; Humans; Levamisole; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Polymorphism, Genetic; Prognosis; Survival Rate | 2013 |
The diagnostic role of diffusion tensor imaging in multifocal inflammatory leukoencephalopathy.
Topics: Antimetabolites; Antineoplastic Agents; Biopsy; Brain; Diffusion Tensor Imaging; Female; Fluorouracil; Functional Laterality; Humans; Leukoencephalopathy, Progressive Multifocal; Levamisole; Middle Aged | 2014 |
Predicting events in clinical trials using two time-to-event outcomes.
Topics: Biometry; Clinical Trials as Topic; Colonic Neoplasms; Fluorouracil; Humans; Levamisole; Models, Statistical; Time Factors; Treatment Outcome | 2018 |
Optimal duration of adjuvant therapy for stage III colon cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Fluorouracil; Guideline Adherence; Humans; Leucovorin; Levamisole; Meta-Analysis as Topic; Multicenter Studies as Topic; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Prognosis; Prospective Studies; Risk; Treatment Outcome | 2019 |